| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |